platoseedplatoseed
Agent Platform for Life Sciences
It takes 500,000 days of office work to bring a drug to market. We want to make it 5. To get there, we need agents doing most of the work. Today, our research agent is the best way to know what the FDA thinks. Users ask a question and get an answer backed by up to 1,000 documents, where each statement has a citation. It’s the best because we have the best retrieval engine. We’ve tuned it on our life science-specific dataset, and we find what others miss. As more teams use Rhizome, we gain more data on what regulatory professionals actually need, which makes retrieval even better. This flywheel is how we become the retrieval engine that powers all human and agent work in life sciences. Chetan started his career as a research engineer, but quickly realized he enjoyed building more than research. He joined EvolutionaryScale as their sole founding product engineer, launching their developer-scientist platform and scaling to tens of thousands of users and billions of API calls. He was also #16 at Instabase helping banks with document processing, closing $7m as the technical closer. Agents can do magical things today, but most in life sciences only use them to edit emails. Agents are missing the context they need to 100x the number of drugs we can bring to market. Rhizome AI is focused on that critical problem.
Rhizome AI provides an agent platform for life sciences that delivers regulator-focused research, offering fast access to a large corpus of health authority documents with citation-backed answers. It emphasizes hallucination-free, cited responses drawn from regulatory and clinical datasets across multiple markets. Pricing shows tiered access including individual, professional, business, and enterprise plans.
Users query regulatory or clinical questions and Rhizome returns answers that cite up to 1,000 documents from health authority databases. The platform aggregates 44.1M documents across 10 countries and 43 datasets, offering datasets for FDA, EMA, and other regions, with grounding and inference-time checks to minimize hallucinations. Pricing tiers provide immediate access to databases per seat or organization, with features like source viewing, citations, and collaborative access across regions.
Who it’s for: Regulatory affairs teams and professionals in biotech/pharma, including directors and managers responsible for FDA/EMA submissions, regulatory science, and compliance across global markets.
Customers: 2,800+ ANSWERS · 20+ CUSTOMERS
Backed by Y Combinator; customer testimonials; multiple pricing tiers; enterprise and global dataset access
Building an agent platform for life sciences. Software engineer who's closed millions in enterprise deals - $7m in technical close at Instabase - co-author of a paper on the cover of science magazine (esm3) - first used vector db's in 2016 for image retrieval
Instantly answer regulatory questions with up to 1,000 documents from public health authority databases without hallucinations
Rhizome AI announces a product that answers regulatory questions for life sciences teams by reading up to 1,000 documents from regulatory and clinical databases with citations, aiming to reduce hallucinations and align with FDA thinking. Target users are regulatory affairs, R&D, and quality teams in biotech/medtech, delivering fast, citation-backed, thorough research on regulatory questions.
AI-native platform for Life-Sciences Documentation
Full stack AI Agents accelerating Biopharma R&D
